Page last updated: 2024-08-23

diltiazem and s 8932

diltiazem has been researched along with s 8932 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Brun, P; Constant, S; Dubois, J; Dulière, V; Errazuriz-Cerda, E; Fouret, J; Gaymard, A; Julien, T; Lescure, FX; Lina, B; Padey, B; Pizzorno, A; Poissy, J; Rosa-Calatrava, M; Terrier, O; Traversier, A; Trouillet-Assant, S; Yazdanpanah, Y	1
Bando, Y; Ishii, H; Otori, K; Yokota, N	1

Other Studies

2 other study(ies) available for diltiazem and s 8932

Article	Year
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell reports. Medicine, 2020, 07-21, Volume: 1, Issue:4 Topics: Adenosine Monophosphate; Airway Remodeling; Alanine; Animals; Antiviral Agents; Bronchi; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Diltiazem; Drug Synergism; Humans; Immunity, Innate; Models, Biological; Nose; Respiratory Mucosa; SARS-CoV-2; Vero Cells	2020
[Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amiodarone; Anticoagulants; Atorvastatin; Bisoprolol; COVID-19 Drug Treatment; Dexamethasone; Diltiazem; Drug Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Warfarin	2022

Article

Year

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.

Cell reports. Medicine, 2020, 07-21, Volume: 1, Issue:4

Topics: Adenosine Monophosphate; Airway Remodeling; Alanine; Animals; Antiviral Agents; Bronchi; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Diltiazem; Drug Synergism; Humans; Immunity, Innate; Models, Biological; Nose; Respiratory Mucosa; SARS-CoV-2; Vero Cells

2020

[Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:10

Topics: Adenosine Monophosphate; Alanine; Amiodarone; Anticoagulants; Atorvastatin; Bisoprolol; COVID-19 Drug Treatment; Dexamethasone; Diltiazem; Drug Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Warfarin

2022